Similar articles

• Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.

  Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A; ISAR-LEFT MAIN Study Investigators. Tiroch K, et al. JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11. JACC Cardiovasc Interv. 2014. PMID: 24332416 Clinical Trial.
• Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

  Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ. Park DW, et al. J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097. J Am Coll Cardiol. 2010. PMID: 20946993
• Characteristics and outcomes of patients with percutaneous coronary intervention for unprotected left main coronary artery disease: a Hong Kong experience.

  Lo KY, Chan CK. Lo KY, et al. Hong Kong Med J. 2014 Jun;20(3):187-93. doi: 10.12809/hkmj134069. Epub 2014 May 9. Hong Kong Med J. 2014. PMID: 24812198
• Left Main Disease: What Is the Correct Approach to Revascularization?

  Rab T, King SB 3rd. Rab T, et al. Cardiol Rev. 2018 Sep/Oct;26(5):219-229. doi: 10.1097/CRD.0000000000000213. Cardiol Rev. 2018. PMID: 29794807 Review.
• Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.

  Park DW, Park SJ. Park DW, et al. Circ Cardiovasc Interv. 2017 Jun;10(6):e004792. doi: 10.1161/CIRCINTERVENTIONS.117.004792. Circ Cardiovasc Interv. 2017. PMID: 28607000 Review.